| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 35,259,261 | 45,816,065 | 45,500,098 | | Cost of Revenue | 9,288,279 | 10,619,644 | 9,815,091 | | | Gross Profit | 25,970,982 | 35,196,421 | 35,685,007 | | | Operating Expenses | | Research Development | 5,329,720 | 6,645,017 | 6,772,609 | | Selling General and Administrative | 11,085,122 | 11,816,027 | 14,268,125 | | Non Recurring | (783,314) | (387,476) | (562,262) | | Others |
-
| 2,041,241 | 2,682,008 | | | | Total Operating Expenses |
-
| 20,114,808 | 23,160,480 | | | | Operating Income or Loss | 10,339,454 | 15,081,612 | 12,524,526 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 453,193 | 569,231 | 881,595 | | Earnings Before Interest And Taxes | 10,862,146 | 15,750,708 | 15,886,342 | | Interest Expense | 1,220,580 | 866,828 | 607,321 | | Income Before Tax | 9,641,566 | 14,883,880 | 15,279,021 | | Income Tax Expense | 2,819,061 | 4,278,217 | 3,967,178 | | Minority Interest |
-
|
-
| (213,542) | | | | Net Income From Continuing Ops | 6,822,505 | 10,605,663 | 8,727,791 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| 19,591 | | Other Items |
-
|
-
|
-
| | | | Net Income | 6,822,505 | 10,605,663 | 8,747,382 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,822,505 | $10,605,663 | $8,747,382 |
|
0.29% Nasdaq 
Income Statement
